• Seeking Alpha

ProNephro AKI™ (NGAL), til tidlig diagnosticering af akut nyreskade, er nu kommercielt tilgængelig på laboratorier i USA gennem BioPortos samarbejde med Roche Diagnostics.

Seeking Alpha / 40 minutes from now 1 Views

28. august 2025
Meddelelse

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
ProNephro AKI™ (NGAL), early detection test for Acute Kidney Injury, now commercially available to US Labs through BioPorto’s collaboration with Roche Diagnostics.
Next post
Sai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL

Comments

Just Posted

  • Ormat Technologies Announces Strategic Commercial Agreement With Sage Geosystems Inc.

    3 hours from now

  • La-Z-Boy Incorporated Announces Participation In Goldman Sachs 32nd Annual Global Retailing Conference

    3 hours from now

  • SEGG Media backed Veloce Media Group boasts strong quarter with blue-chip partnerships for newly acquired Quadrant

    3 hours from now

  • YY Group Signs Strategic MOU with Keenon Robotics

    3 hours from now

  • Keskisuomalainen Oyj:n puolivuosikatsaus 1.1.–30.6.2025

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1782

Categories

  • Seeking Alpha 1782

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts